-
Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome
J. Wouter Jukema, Nicolaas J.M. van Neer, Michael J. Szarek, Christa M. Cobbaert, Vera Bittner, Markus Schwertfeger, +8 more
2citations -
Relation between coronary artery calcium score and cardiovascular events in Hodgkin lymphoma survivors: a cross-sectional matched cohort study
Elissa A. S. Polomski, Julius Cornelis Heemelaar, Michiel Alexander De Graaf, Augustinus D. G. Krol, Marloes Louwerens, J. Lauran Stöger, +3 more
2citations -
Awareness and perceptions of cardiologists towards systemic inflammation in atherosclerotic cardiovascular disease: A multi-national survey across 5 geographical regional sub-groups2024 European Heart Journal article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access
Alberico Luigi Catapano, Issei Komuro, Amir Abbas Mohseni Zonoozi, J Q Qian, Jose F Saraiva, Abhijit Shete, +1 more
1citations -
Takotsubo syndrome diagnosis: the biomarker-based BioTAK score2026 European Heart Journal article Medicine Takotsubo Cardiomyopathy and Associated Phenomena Open access
Florian A. Wenzl, Victor Schweiger, Maria Anna Smolle, Alexander T. Akhmedov, Peizhi Wang, Tetiana Lapikova-Bryhinska, +16 more
1citations -
Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
Darren K. McGuire, J Rosenstock, Odd-Erik Johansen, Bernard Zinman, Kamlesh K. Khunti, Michaela Mattheus, +3 more
1citations